Loop Industries Valuation
Is 3L9 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 3L9 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 3L9 (€1.33) is trading below our estimate of fair value (€15.86)
Significantly Below Fair Value: 3L9 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 3L9?
Key metric: As 3L9 barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is 3L9's PB Ratio? | |
|---|---|
| PB Ratio | 13.9x |
| Book | US$4.83m |
| Market Cap | US$67.14m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 699.4x |
| Enterprise Value/EBITDA | -3.7x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 3L9's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.2x | ||
IBU IBU-tec advanced materials | 0.6x | 109.4% | €33.3m |
SIM0 SIMONA | 1x | n/a | €357.0m |
BNN BRAIN Biotech | 4.2x | 71.5% | €68.8m |
3330 Decheng Technology | 3.2x | n/a | €1.9m |
3L9 Loop Industries | 13.9x | 63.5% | €67.1m |
Price-To-Book vs Peers: 3L9 is expensive based on its Price-To-Book Ratio (13.9x) compared to the peer average (2.2x).
Price to Book Ratio vs Industry
How does 3L9's PB Ratio compare vs other companies in the DE Chemicals Industry?
Price-To-Book vs Industry: 3L9 is expensive based on its Price-To-Book Ratio (13.9x) compared to the European Chemicals industry average (1.4x).
Price to Book Ratio vs Fair Ratio
What is 3L9's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 13.9x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 3L9's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Stanmore Resources
AU$2.8b
Engages in the exploration, development, production, and sale of metallurgical coal in Australia.
S0D
AU$1.91
7D
4.9%
1Y
-15.5%
Tokuyama
JP¥196.7b
Produces and sells various chemical products in Japan.
TBT
JP¥16.60
7D
5.7%
1Y
14.5%
Arkema
€5.7b
Manufactures and sells specialty chemicals and advanced materials worldwide.
V1S
€74.55
7D
-4.4%
1Y
-19.9%